{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:38:32Z","timestamp":1760985512606,"version":"3.41.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/COBRA","award":["P20GM109005"],"award-info":[{"award-number":["P20GM109005"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.phrs.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T19:31:31Z","timestamp":1473881491000},"page":"335-347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"PA","title":["Antinociceptive effects of the 6- O -sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors"],"prefix":"10.1016","volume":"113","author":[{"given":"Jai Shankar K.","family":"Yadlapalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin M.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Ketkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-4261","authenticated-orcid":false,"given":"Anqi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narasimha R.","family":"Penthala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Eoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Prather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim","family":"Dobretsov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1312-6150","authenticated-orcid":false,"given":"Peter A.","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.09.012_bib0005","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0140-6736(99)03528-X","article-title":"Opioids in pain management","volume":"353","author":"McQuay","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2016.09.012_bib0010","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1124\/jpet.110.172866","article-title":"In vivo characterization of MMP-2200 a mixed delta\/mu opioid agonist, in mice","volume":"336","author":"Lowery","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.09.012_bib0015","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.lfs.2009.02.025","article-title":"Bi- or multifunctional opioid peptide drugs","volume":"86","author":"Schiller","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2016.09.012_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2010.08.034","article-title":"Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain","volume":"648","author":"Holtman","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.09.012_bib0025","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0024-3205(87)90710-7","article-title":"Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position","volume":"41","author":"Oguri","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2016.09.012_bib0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jps.2600740804","article-title":"Analgesic potencies of morphine 3- and 6-sulfates after intracerebroventricular administration in mice: relationship to structural characteristics defined by mass spectrometry and nuclear magnetic resonance","volume":"74","author":"Brown","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2016.09.012_bib0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0091-3057(95)02067-5","article-title":"3-O-acetylmorphine-6-O-sulfate: a potent, centrally acting morphine derivative","volume":"53","author":"Houdi","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2016.09.012_bib0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0024-3205(72)90003-3","article-title":"Chemical synthesis and analgesic effect of morphine ethereal sulfates","volume":"11","author":"Mori","year":"1972","journal-title":"Life Sci. I"},{"key":"10.1016\/j.phrs.2016.09.012_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)01766-7","article-title":"Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate","volume":"842","author":"Zuckerman","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.09.012_bib0050","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1021\/jm000077y","article-title":"Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability","volume":"43","author":"Bilsky","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2016.09.012_bib0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-3565(25)21481-1","article-title":"Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse","volume":"230","author":"Porreca","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.09.012_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1744-8069-9-8","article-title":"Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels","volume":"9","author":"Pradhan","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.phrs.2016.09.012_bib0065","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.09.012_bib0070","doi-asserted-by":"crossref","first-page":"PL121","DOI":"10.1016\/0024-3205(94)90062-0","article-title":"Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors","volume":"55","author":"Kamei","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2016.09.012_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(92)90655-S","article-title":"Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists","volume":"571","author":"Kamei","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.09.012_bib0080","series-title":"Animal Models of Pain","first-page":"147","article-title":"Animal models of diabetic neuropathic pain","author":"Dobretsov","year":"2010"},{"key":"10.1016\/j.phrs.2016.09.012_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3565(24)37362-8","article-title":"Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics?","volume":"285","author":"Courteix","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.09.012_bib0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3959(00)00386-9","article-title":"Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats","volume":"90","author":"Zurek","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2016.09.012_bib0095","first-page":"S1","article-title":"Standards of medical care in diabetes","volume":"39","author":"American Diabeties Association","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2016.09.012_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2010.06.059","article-title":"Comparison of metabolic and neuropathy profiles of rats with streptozotocin-induced overt and moderate insulinopenia","volume":"170","author":"Romanovsky","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.09.012_bib0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1085-9489.2004.009204.x","article-title":"Relevance of hyperglycemia to early mechanical hyperalgesia in streptozotocin-induced diabetes","volume":"9","author":"Romanovsky","year":"2004","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.phrs.2016.09.012_bib0110","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1016\/j.bmcl.2006.05.060","article-title":"Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners","volume":"16","author":"Crooks","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2016.09.012_bib0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-3565(25)22889-0","article-title":"Chronic stress, aging and morphine analgesia: chronic stress affects the reactivity to morphine in young mature but not old rats","volume":"233","author":"Girardot","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.09.012_bib0120","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.300.2.588","article-title":"Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats","volume":"300","author":"Powell","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.09.012_bib0125","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1476-5381.2011.01544.x","article-title":"Novel opioid cyclic tetrapeptides: trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting kappa opioid receptor antagonism","volume":"165","author":"Ross","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.09.012_bib0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1369-1600.2010.00226.x","article-title":"Systemic kappa-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats","volume":"16","author":"Walker","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.phrs.2016.09.012_bib0135","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0024-3205(01)01550-8","article-title":"Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites","volume":"70","author":"Narita","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2016.09.012_bib0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1476-5381.1992.tb12785.x","article-title":"Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats","volume":"107","author":"Crook","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.09.012_bib0145","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","article-title":"Extremely-long lasting antagonistic actions of nor-binaltrophimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"Horan","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.09.012_bib0150","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuropharm.2012.06.046","article-title":"AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid\/cannabinoid interaction studies","volume":"63","author":"Seely","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.09.012_bib0155","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1124\/jpet.105.085282","article-title":"The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors","volume":"314","author":"Shoemaker","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.09.012_bib0160","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0026-895X(24)26511-1","article-title":"Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies","volume":"57","author":"Prather","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.09.012_bib0165","first-page":"957","article-title":"The diabetes mass screening in the county of ruegen","volume":"18","author":"Heik","year":"1963","journal-title":"Z. Gesamte Inn. Med."},{"key":"10.1016\/j.phrs.2016.09.012_bib0170","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2016.09.012_bib0175","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11111","article-title":"Structure of the delta-opioid receptor bound to naltrindole","volume":"485","author":"Granier","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.09.012_bib0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the micro-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.09.012_bib0185","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2016.09.012_bib0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2016.09.012_bib0195","first-page":"859","article-title":"Buprenorphine \u2013 an attractive opioid with underutilized potential in treatment of chronic pain","volume":"8","author":"Khanna","year":"2015","journal-title":"J. Pain Res."},{"key":"10.1016\/j.phrs.2016.09.012_bib0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/38730","article-title":"Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor","volume":"389","author":"Pan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.09.012_bib0205","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1213\/01.ANE.0000094334.12027.06","article-title":"Differential opioid inhibition of C- and A delta- fiber mediated thermonociception after stimulation of the nucleus raphe magnus","volume":"98","author":"Lu","year":"2004","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.phrs.2016.09.012_bib0210","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1073\/pnas.94.4.1544","article-title":"Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia","volume":"94","author":"Sora","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.09.012_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00003643-200403000-00003","article-title":"Supraspinal and spinal cord opioid receptors are responsible for antinociception following intrathecal morphine injections","volume":"21","author":"Goodchild","year":"2004","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.phrs.2016.09.012_bib0220","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","article-title":"Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2016.09.012_bib0225","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neuroscience.2006.12.016","article-title":"Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons","volume":"145","author":"Chen","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.09.012_bib0230","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1152\/jn.2002.87.6.2726","article-title":"Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats","volume":"87","author":"Chen","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.phrs.2016.09.012_bib0235","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/00000542-200212000-00037","article-title":"Functional mu opiod receptors are reduced in the spinal cord dorsal horn of diabetic rats","volume":"97","author":"Chen","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2016.09.012_bib0240","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000542-200312000-00026","article-title":"Antinociceptive effect of morphine but not mu opiod receptor number, is attenuated in the spinal cord of diabetic rats","volume":"99","author":"Chen","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2016.09.012_bib0245","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jpain.2015.01.353","article-title":"Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu\/delta agonist in the treatment of diabetic neuropathic pain","volume":"16","author":"Yadlapalli","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.phrs.2016.09.012_bib0250","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.lfs.2013.09.016","article-title":"Novel fentanyl-based dual mu\/delta-opioid agonists for the treatment of acute and chronic pain","volume":"93","author":"Podolsky","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2016.09.012_bib0255","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ardp.201300380","article-title":"Potent biphalin analogs with micro\/delta mixed opioid activity: in vivo and in vitro biological evaluation","volume":"347","author":"Costante","year":"2014","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.phrs.2016.09.012_bib0260","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.113.208108","article-title":"Orally active opioid mu\/delta dual agonist MGM-16 a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice","volume":"348","author":"Matsumoto","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816301712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816301712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:50:26Z","timestamp":1749581426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816301712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":52,"alternative-id":["S1043661816301712"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.09.012","relation":{},"ISSN":["1043-6618"],"issn-type":[{"type":"print","value":"1043-6618"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}